首页 | 本学科首页   官方微博 | 高级检索  
     


Tissue microarray analysis of RANKL in cutaneous lupus erythematosus and psoriasis
Authors:Toberer Ferdinand  Sykora Jaromir  Göttel Daniel  Ruland Vincent  Hartschuh Wolfgang  Enk Alexander  Luger Thomas A  Beissert Stefan  Loser Karin  Joos Stefan  Krammer Peter H  Kuhn Annegret
Affiliation:1. Institute of Immunogenetics, Tumorimmunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany;2. Department of Dermatology, University of Heidelberg, Heidelberg, Germany;3. Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany;4. Institute of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany;5. Department of Dermatology, University of Münster, Münster, Germany
Abstract:Recently, it was discovered that the receptor activator of nuclear factor κB (RANK)/RANK ligand (RANKL) is part of an important signal transduction pathway for tissue homoeostasis. Therefore, we were interested in investigating RANKL expression in the epidermis of skin lesions from patients with different subtypes of cutaneous lupus erythematosus (CLE) and psoriasis as well as normal healthy donors. Using the tissue microarray technique, skin biopsy specimens were evaluated by immunohistochemistry. RANKL showed a significantly increased expression in the epidermis of skin biopsy specimens from patients with psoriasis (median: 4, range: 0-5) compared to patients with CLE (median: 0, range: 0-4) (P<0.001). No significant differences in epidermal RANKL expression between the CLE subtypes were detected. These data show a different expression of RANKL in the epidermis of skin lesions from patients with CLE compared to those with psoriasis suggesting that RANKL might play an important role in the pathogenesis of the disease.
Keywords:cutaneous lupus erythematosus  psoriasis  RANKL  skin  tissue microarray
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号